US Anthrax Vaccine Market Segmentation
US Anthrax Vaccine Vaccine Type Outlook (USD Billion, 2019-2032)
US Anthrax Vaccine Applications Outlook (USD Billion, 2019-2032)
US Anthrax Vaccine Distribution Channel Outlook (USD Billion, 2019-2032)
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. US ANTHRAX VACCINE MARKET, BY VACCINE TYPE
6.1. Overview
6.2. Cell Free PA Vaccine
6.3. Anthrax Vaccine Adsorbed (AVA)
6.4. Anthrax Vaccine Precipitated (AVP)
6.5. Live Attenuated Vaccine
7. US ANTHRAX VACCINE MARKET, BY APPLICATIONS
7.1. Overview
7.2. Animal Use
7.3. Human Use
8. US ANTHRAX VACCINE MARKET, BY DISTRIBUTION CHANNEL
8.1. Overview
8.2. Hospitals
8.3. Pharmacies
8.4. Other Distribution Channels
9. COMPETITIVE LANDSCAPE
9.1. Overview
9.2. Competitive Analysis
9.3. Market Share Analysis
9.4. Major Growth Strategy in the US Anthrax Vaccine Market,
9.5. Competitive Benchmarking
9.6. Leading Players in Terms of Number of Developments in the US Anthrax Vaccine Market,
9.7. Key developments and Growth Strategies
9.7.1. New Product Launch/Service Deployment
9.7.2. Merger & Acquisitions
9.7.3. Joint Ventures
9.8. Major Players Financial Matrix
9.8.1. Sales & Operating Income, 2023
9.8.2. Major Players R&D Expenditure, 2023
10. COMPANY PROFILES
10.1. Merck & Co., Inc.
10.1.1. Company Overview
10.1.2. Financial Overview
10.1.3. Products Offered
10.1.4. Key Developments
10.1.5. SWOT Analysis
10.1.6. Key Strategies
10.2. Emergent Bio-Solutions
10.2.1. Company Overview
10.2.2. Financial Overview
10.2.3. Products Offered
10.2.4. Key Developments
10.2.5. SWOT Analysis
10.2.6. Key Strategies
10.3. Zoetis, Inc.
10.3.1. Company Overview
10.3.2. Financial Overview
10.3.3. Products Offered
10.3.4. Key Developments
10.3.5. SWOT Analysis
10.3.6. Key Strategies
10.4. PharmAthene, Inc
10.4.1. Company Overview
10.4.2. Financial Overview
10.4.3. Products Offered
10.4.4. Key Developments
10.4.5. SWOT Analysis
10.4.6. Key Strategies
10.5. Biogenesis Bago S.A
10.5.1. Company Overview
10.5.2. Financial Overview
10.5.3. Products Offered
10.5.4. Key Developments
10.5.5. SWOT Analysis
10.5.6. Key Strategies
10.6. Porton Biopharma Limited
10.6.1. Company Overview
10.6.2. Financial Overview
10.6.3. Products Offered
10.6.4. Key Developments
10.6.5. SWOT Analysis
10.6.6. Key Strategies
10.7. Colorado Serum
10.7.1. Company Overview
10.7.2. Financial Overview
10.7.3. Products Offered
10.7.4. Key Developments
10.7.5. SWOT Analysis
10.7.6. Key Strategies
10.8. Merial, Inc.
10.8.1. Company Overview
10.8.2. Financial Overview
10.8.3. Products Offered
10.8.4. Key Developments
10.8.5. SWOT Analysis
10.8.6. Key Strategies
10.9. Tiankang
10.9.1. Company Overview
10.9.2. Financial Overview
10.9.3. Products Offered
10.9.4. Key Developments
10.9.5. SWOT Analysis
10.9.6. Key Strategies
10.10. Agrovet
10.10.1. Company Overview
10.10.2. Financial Overview
10.10.3. Products Offered
10.10.4. Key Developments
10.10.5. SWOT Analysis
10.10.6. Key Strategies
10.11. Bayer AG
10.11.1. Company Overview
10.11.2. Financial Overview
10.11.3. Products Offered
10.11.4. Key Developments
10.11.5. SWOT Analysis
10.11.6. Key Strategies
11. APPENDIX
11.1. References
11.2. Related Reports 
LIST OF TABLES
TABLE 1 US ANTHRAX VACCINE MARKET, SYNOPSIS, 2019-2032
TABLE 2 US ANTHRAX VACCINE MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 US ANTHRAX VACCINE MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)
TABLE 4 US ANTHRAX VACCINE MARKET, BY APPLICATIONS, 2019-2032 (USD BILLION)
TABLE 5 US ANTHRAX VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE US ANTHRAX VACCINE MARKET
FIGURE 3 MARKET DYNAMICS FOR THE US ANTHRAX VACCINE MARKET
FIGURE 4 US ANTHRAX VACCINE MARKET, SHARE (%), BY VACCINE TYPE, 2023
FIGURE 5 US ANTHRAX VACCINE MARKET, SHARE (%), BY APPLICATIONS, 2023
FIGURE 6 US ANTHRAX VACCINE MARKET, SHARE (%), BY DISTRIBUTION CHANNEL, 2023
FIGURE 7 US ANTHRAX VACCINE MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 8 MERCK & CO., INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 9 MERCK & CO., INC.: SWOT ANALYSIS
FIGURE 10 EMERGENT BIO-SOLUTIONS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 11 EMERGENT BIO-SOLUTIONS: SWOT ANALYSIS
FIGURE 12 ZOETIS, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 13 ZOETIS, INC.: SWOT ANALYSIS
FIGURE 14 PHARMATHENE, INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 PHARMATHENE, INC: SWOT ANALYSIS
FIGURE 16 BIOGENESIS BAGO S.A.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 BIOGENESIS BAGO S.A: SWOT ANALYSIS
FIGURE 18 PORTON BIOPHARMA LIMITED: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 PORTON BIOPHARMA LIMITED: SWOT ANALYSIS
FIGURE 20 COLORADO SERUM: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 COLORADO SERUM: SWOT ANALYSIS
FIGURE 22 MERIAL, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 MERIAL, INC.: SWOT ANALYSIS
FIGURE 24 TIANKANG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 TIANKANG: SWOT ANALYSIS
FIGURE 26 AGROVET: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 AGROVET: SWOT ANALYSIS
FIGURE 28 BAYER AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 BAYER AG: SWOT ANALYSIS
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
